CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Financial Officer acquired 294,473 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 35,389 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 196,316 shares (conversion)
- 4 Open-market sale Chief Executive Officer sold 200,000 shares at an average $14.87 ($2,974,700)
- 4 Open-market sale Chief Scientific Officer sold 202,908 shares at an average $14.85 ($3,012,462)
- 4 Open-market buy Chief Financial Officer bought 10,870 shares at $9.09 ($98,808)
- 4 Open-market sale Former 10% Owner sold 6,499,978 shares at an average $7.21 ($46,868,184)
- 4 Conversion Chief Scientific Officer acquired 48,978 shares (conversion)
- 4 Open-market sale Director sold 23,500 shares at $48.79 ($1,146,565)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 95,763 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 95,763 shares (grant or award)
Page 2 of 5 · 97 filings